Objective-Polymorphisms in the platelet-endothelial cell adhesion molecule (PECAM-1)-1 gene are linked to increased risk of coronary artery disease. Because PECAM-1 has been demonstrated to form a mechanosensory complex that can modulate inflammatory responses in murine arterial endothelial cells, we hypothesized that PECAM-1 contributes to atherogenesis in a shear-dependent and site-specific manner. Approach and Results-ApoE -/mice that were wild-type, heterozygous, or deficient in PECAM-1 were placed on a highfat diet. Detailed analysis of the aorta at sites with differing hemodynamics revealed that PECAM-1-deficient mice had reduced disease in areas of disturbed flow, whereas plaque burden was increased in areas of steady, laminar flow. In concordance with these observations, bone marrow chimera experiments revealed that hematopoietic PECAM-1 resulted in accelerated atheroma formation in areas of laminar and disturbed flow, however endothelial PECAM-1 moderated disease progression in areas of high sheer stress. Moreover, using shear stress-modifying carotid cuffs, PECAM-1 was shown to promote macrophage recruitment into lesions developing in areas of low shear stress.
P latelet-endothelial cell adhesion molecule (PECAM)-1 is a type-1 transmembrane glycoprotein of the immunoglobulin superfamily that is expressed on platelets, most leukocyte subsets, and at endothelial cell (EC) junctions. [1] [2] [3] [4] [5] PECAM-1 sustains both homophilic interaction (PECAM-1-PECAM-1) and heterophilic interactions with integrin αvβ3, CD38, and CD177 and is a highly efficient signaling molecule mediating both outside-in and inside-out signaling. 5, 6 Because of its identification within the plasma membrane of EC, 7 and its cloning soon thereafter, 8 and subsequent generation of PECAM-1 knockout mouse, 9 the role of PECAM-1 in the vascular system, as well as during inflammatory and autoimmune responses, has been extensively studied. [1] [2] [3] [4] [5] 9, 10 For example, antibody blockade of PECAM-1 function in in vitro adhesion assays limits leukocyte migration through EC monolayers, as well as the directionality of migrating neutrophils under flow conditions. 2, [11] [12] [13] [14] PECAM-1 has also been shown to mediate leukocyte motility and extravasation through the basement membrane in vivo, in response to interleukin-1β but not tumor necrosis factor-α. 5, [15] [16] [17] A mechanosensory role for PECAM-1 was first demonstrated in EC that had been mechanically stimulated or exposed to osmotic stress. 18, 19 Antibody-conjugated magnetic bead ligation of PECAM-1 followed by exposure to a mechanical force resulted in tyrosine phosphorylation of the cytoplasmic tail within 30 seconds. 18, 19 Downstream kinases such as extracellular signal-regulated kinases-1/2 were subsequently activated. 19 EC-expressed PECAM-1 can also form a mechanosensory complex with vascular endothelial growth factor receptor-2 and vascular endothelial-cadherin, which responds to fluid shear stress. 20 Disturbed flow profiles with relatively low and oscillatory shear stress are found in the inner curvature of the aortic arch or at bifurcations in the arterial system, and are associated with localized formation of atheroma. These areas also show activation of the proinflammatory transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells in EC, compared with regions experiencing laminar flow with high levels of shear stress. Importantly, in PECAM-1-deficient mice, EC positioned in the inner curvature of the aortic arch were protected against nuclear factor kappa-lightchain-enhancer of activated B cells activation. 20 However, cultured EC, which had been subjected to PECAM-1 small interfering RNA knock down, did not align in response to laminar high shear, but remained polygonal, 20 a phenotype found in areas of arteries prone to atherogenesis. Generally, laminar shear stress suppresses the inflammatory responses of EC, 21, 22 and we have recently shown that this protective effect also requires expression of PECAM-1. 23 Thus, taken together, these results indicate that PECAM-1 may play roles in the proinflammatory response believed to promote atherogenesis in regions of disturbed flow and in the protective effects of laminar, high shear stress.
The expression of PECAM-1 on EC, platelets, and leukocytes has led investigators to hypothesize that it may play a key role in cardiovascular disease. In humans, population studies have linked single nucleotide polymorphisms of the PECAM-1 gene and elevated levels of soluble PECAM-1 to severe coronary artery stenosis as well as myocardial infarction. [24] [25] [26] [27] In mice, the role of PECAM-1 in atherogenesis remains controversial. Recent studies in the Pecam-1 -/-ApoE -/mouse 28, 29 or Pecam-1 -/ldlr -/mouse 30 on high-fat diet (HFD) have produced conflicting results. Although all the studies agree that PECAM-1 is proatherogenic in the inner curvature of the aortic arch, the site-specific effects of PECAM-1 in the descending aorta are inconsistent between models, with a net proinflammatory 28 or antiinflammatory 30 role of PECAM-1 in lesion formation being observed over the whole aorta.
To investigate the site-specific effects of PECAM-1, we generated Pecam-1 -/-ApoE -/mice and placed them on a HFD to promote atherogenesis. The disease phenotype was dominated by the descending aorta, which delivered a net elevation in plaque burden in the whole aorta. However, a detailed analysis of disease burden at sites subject to different hemodynamic forces showed a reduction of plaque formation in the inner curvature of the aortic arch where low shear stress and complex patterns of flow are apparent. There was also a concomitant elevation in plaque burden in the descending aorta, which is subject to laminar high shear flow. Formation of radiation chimeras revealed that increased plaque burden in the descending aorta was primarily a result of loss of the EC pool of PECAM-1; the hematopoietic pool appeared to be more important for disease progression in the aortic arch. Experiments using shear stress-modifying carotid cuffs in Pecam-1 -/-ApoE -/and ApoE -/mice also showed a reduction in plaque burden in areas of low shear stress in mice deficient in PECAM-1. Interestingly, in this model, we also found a strong dependence on PECAM-1 for recruitment of monocytes into the atheromatous environment.
Results

Effects of PECAM-1 Ablation on the Hematology and Blood Chemistry of the Pecam1 -/-ApoE -/-Mouse
Total white blood cell counts did not vary between ApoE -/-deficient mice with a Pecam-1 -/genotype or the control groups of ApoE -/mice, which were Pecam-1 +/or Pecam-1 +/+ on either dietary regimen (chow versus HFD; Tables I-III in the onlineonly Data Supplement). However, ablation of PECAM-1 did result in a small but significant increase in the percentage of circulating peripheral blood lymphocytes, which in chow-fed animals was associated with a significant reduction in the percentage of circulating monocytes ( Table I in the onlineonly Data Supplement). In animals on HFD, there was a trend toward lower phagocyte (monocytes and polymorphonuclear neutrophils) numbers in the circulation, but this was not significant. Triglyceride and cholesterol levels were elevated significantly by HFD; although triglyceride levels were not sensitive to alterations in genotype, cholesterol levels in ApoE -/mice that were Pecam-1 +/were significantly reduced compared with other genotypes in both dietary regimes. The loss of PECAM-1 did not alter the rate of weight gain over the duration of these experiments ( Table II in 
Site-Specific Effect of PECAM-1 Ablation on Atheroma Formation in the Aorta of the Pecam1 -/-ApoE -/-Mouse
In mice on a chow diet, plaque burden over the whole aorta was low (≈7%), and was not affected by genotype. A full analysis of the animals on this dietary regimen can be found in Figure  I the online-only Data Supplement. ApoE -/animals fed a HFD showed an increase in plaque burden compared with chowfed animals. Interestingly, the loss of PECAM-1 led to a net elevation (≈25%) in disease burden over the whole aorta ( Figure  1A -1C). However, detailed analysis showed that the effects of PECAM-1 ablation were complex and site-specific. Thus, there was significant reduction in plaque burden in the aortic arch, particularly in the inner curvature ( Figure 1D ). In the same animals, the loss of PECAM-1 led to a significant elevation in disease burden in the thoracic and abdominal aortas (ie, the descending aorta; Figure 1E ). No effect of the loss of PECAM-1 was found on atheroma formation in the aortic sinus ( Figure  II the online-only Data Supplement). In the descending aorta, atheroma often occurs at the sites where branching arteries form areas of disturbed flow. In a more detailed analysis ( Figure 2 ), we observed that plaques in the descending aorta were, in general, associated with branch points of smaller arteries, although in some instances, especially in the abdominal aorta, plaques were large enough to encompass an area of vessel wall that included number of branching arteries (data not shown). Interestingly, the number of plaques in the descending aorta did not vary with the loss of PECAM-1; however, the average size of the plaques was significantly larger in Pecam-1 -/-ApoE -/mice. Interestingly, the site-specific effects of the ablation of PECAM-1 on atheroma formation were maintained for an extended period. Thus, in Pecam-1 -/-ApoE -/mice fed a HFD for 24 weeks, there was a ≈23% increase in plaque burden over the whole aorta compared with the control group ( Figure 
Effect of Losing Either Endothelial or Bone Marrow PECAM-1 on Plaque Burden
Because PECAM-1 is expressed widely in cells of hematopoietic origin, as well as EC, we generated bone marrow (BM) chimeras to differentiate the function of these pools. First, in control experiments, it was important to show that patterns in the change of disease burden in irradiated animals was similar to that reported for nonirradiated animals. Thus, ablation of BM in the ApoE -/mouse followed by reconstitution with ApoE -/-BM allowed formation of atherosclerosis ( Figure  3A) . Importantly, the ablation of BM in the Pecam-1 -/-ApoE -/followed by reconstitution with BM from Pecam-1 -/-ApoE -/animals ( Figure 3A -3C) showed an increase in disease across the whole aorta, with a decrease in disease burden in the aortic arch and increased disease in the descending aorta ( Figure 3A -3C), which phenocopied the nonirradiated animals. Further analysis in chimeric animals indicated that differences in disease susceptibility were based on the presence of the different pools of PECAM-1. Thus, in the arch ( Figure 3B ), reconstitution of the Pecam-1 -/-ApoE -/animals with Pecam-1 +/+ ApoE -/-BM ( Figure 3B ) significantly exacerbated disease, when compared Figure 3B ) and Pecam-1 +/+ ApoE -/mice receiving Pecam-1 +/+ ApoE -/-BM ( Figure 3B ). In contrast, the opposite construct (ie, reconstituting EC PECAM-1 in the double knockout mice) had no significant effect when compared with Pecam-1 -/-ApoE -/mice receiving Pecam-1 -/-ApoE -/-BM. We interpret this to show a dominant effect of the BM pool in disease progression at this site. Interestingly, in the descending aorta ( Figure 3C ), reconstitution of Pecam-1 -/-ApoE -/with BM from Pecam-1 +/+ ApoE -/mice ( Figure 3C ) had no significant effect on disease compared with Pecam-1 -/-ApoE -/mice receiving Pecam-1 -/-ApoE -/-BM ( Figure 3C ). However, the opposite construct (ie, reconstituting the Pecam-1 Figure 3C ). Thus, in the descending aorta, the presence of PECAM-1 in the BM pool had no significant effect on disease progression when compared with the Pecam-1 -/-ApoE -/mice receiving Pecam-1 -/-ApoE -/-BM ( Figure 3C ). However, the EC pool had antiatherogneic properties at this site and conferred rescue from disease. Interestingly, however, the BM pool significantly increased disease progression in the descending aorta when compared with the Pecam-1 +/+ ApoE -/mice receiving Pecam-1 +/+ ApoE -/-BM.
PECAM-1 Is Proatherogenic in Regions of Low Shear Stress Generated by Restrictive Carotid Cuffs
We used surgically implanted shear stress-modifying carotid cuffs to generate areas of defined low shear stress in the common carotid artery in which plaque was evident ( Figure  4A ). 31 Extensive control studies for this model have been described in detail in Cheng et al. 32 Briefly, these studies used nonflow-altering control cuffs (constant diameter) that were placed around the vessel touching the adventitial layer, to test for nonspecific effects. Short-lasting placement (7 days) did not change endothelial nitric oxide synthase expression, and longlasting placements (9 weeks; unpublished data) did not induce plaques or inflammatory responses. Analysis after 9 weeks of HFD showed that there was no disease in the common carotid artery of ApoE -/control mice undergoing sham surgery ( Figure 4B ). In the ApoE -/mouse, a large plaque developed in the low shear environment, no plaque was evident in the high shear region, and a small plaque was found downstream of the cuff in the region with oscillatory-like patterns of flow ( Figure  4A and 4B) , patterns in agreement with other reports using this methodology. 31 In the common carotid artery of ApoE -/-/Pecam-1 -/mice, a significant reduction in plaque burden was seen in the low shear region ( Figure 4B ). Cross sections of the carotid arteries were also examined, and oil red O staining confirmed that lack of PECAM-1 dramatically diminished the deposition of lipid within the artery wall in the low shear region ( Figure 5A and 5B). Interestingly, even though there was no change in plaque burden or in lipid deposition in the region subjected to oscillatory shear, collagen deposition was significantly reduced in this area ( Figure 5C and 5D ). Analysis of the common carotid artery for macrophage content also revealed interesting variations between hemodynamic environments. Thus, plaques in the low shear environment were rich in CD68 + cells, but ablation of Pecam-1 significantly reduced the presence of macrophages in the double knockout mouse ( Figure 6 ). No significant differences were found in smooth muscle cell actin content or CD3 + T-cells between mouse groups (data not shown).
Discussion
PECAM-1 is expressed by EC and hematopoietic cells, such as leukocytes and platelets. It is well known to act as a transducer of mechanical signals in EC, 19, 20, [33] [34] [35] and also to regulate migration of leukocytes through endothelium. 12, 36, 37 In the past decade, evidence that PECAM-1 is important in cardiovascular disease has emerged. Polymorphisms of PECAM-1 have been linked to coronary artery disease and myocardial infarction in various ethnic groups. [24] [25] [26] [27] However, the functional basis of such pathogenesis is unclear, and to attempt to clarify this, a number of studies have now been conducted in whole-body PECAM-1 knockouts superimposed on murine models of atherosclerosis (the low-density lipoprotein receptor [LDLR] -/or apolipoprotein E [ApoE] -/mice). Unfortunately, even separate studies conducted on mice with the same genetic background have used different dietary regimen and assessed disease at different time points, which makes comparative interpretation problematic. However, previous reports do agree that regulation of disease burden by PECAM-1 is strongly associated with differences in the local hemodynamic environment. Unfortunately, even these interesting variations are not consistent between models, or even between studies using the same model. Thus, to understand the role of PECAM-1 in atherogenesis more thoroughly, we generated Pecam-1 -/-ApoE -/mice and evaluated 2 models: natural variation in disease in different regions of the arterial tree, which experience different patterns of blood flow; and placement of a carotid cuff to generate disease in defined areas of low shear stress and oscillating shear stress, which would be free of disease otherwise.
Effects of PECAM-1 Ablation on Disease Burden in the Whole Aorta
Using the first model to assess natural variation in disease, mice were subjected to a HFD-feeding regimen for either 13 or 24 weeks. On general analysis, ApoE -/mice lacking PECAM-1 in EC and leukocytes showed elevated levels of plaque in a simple analysis of total disease burden in the whole aorta. This is in agreement with the study utilizing the ldlr -/-/Pecam-1 -/mouse by Goel et al, 30 however it contradicts the reported decrease in total burden arising from PECAM-1 ablation in the ApoE mouse. 28, 29 When we used BM chimeras to discriminate between the function of the EC and hematopoietic pools (BM), the EC pool had a strong regulatory role on disease progression so that, in the presence of EC PECAM-1, disease was significantly reduced compared with animals completely lacking in PECAM-1, however the presence of BM PECAM-1 significantly increased disease compared with animals either completely lacking or completely expressing PECAM-1. Importantly, as the aorta is a complex vessel that is subjected to variation in the hemodynamic environment in a site-specific manner, such a crude analysis of plaque burden is insufficiently stringent to describe the effects of PECAM-1 ablation on the anatomical patterning of atherosclerosis.
Effects of PECAM-1 Ablation on Disease Burden in Areas of Low Shear Stress
In the aortic arch, which is an anatomic site subject to low shear and oscillatory flow, we observed that total ablation of PECAM-1 in ApoE -/mice fed a HFD for 13 or 24 weeks resulted in decreased plaque burden. More detailed analysis of the aortic arch at the sites of the inner and outer curvature revealed a decrease in plaque formation at the inner curvature, but no significant difference at the outer curvature. These observations are in broad agreement with all previous reports, irrespective of the geneotype of the models used (ie, ApoE -/-/Pecam-1 -/or ldlr -/-/Pecam-1 -/mice). 28, 30 Here, the use of BM chimeras revealed that the presence of BM PECAM-1 significantly increased disease burden compared with both PECAM-1 null mice and mice expressing PECAM-1 on both the BM and EC pools. In contrast, however, abolition of EC PECAM-1 had no significant effect on disease. We interpret these data to show a strong proatherogenic role for the hematopoietic (BM) pool of PECAM-1 in the aortic arch.
In addition to analysis of the aorta, we also used shearmodifying carotid cuffs to generate an area of low flow and an atherosclerotic plaque in the carotid artery. This model demonstrated broadly similar results on ablation of PECAM-1. Thus, plaque burden was significantly reduced in ApoE -/-Pecam-1 -/compared with ApoE -/animals. Interestingly, analysis of the content of these plaques demonstrated a much reduced representation of macrophages in the cellular infiltrate. These data, taken together with the demonstration of the importance of the hematopoietic pool of PECAM-1 in our chimera studies, imply that monocyte PECAM-1 may be important in supporting the trafficking of these cells into plaques that develop in areas of low shear stress.
The above observations made in vivo are well supported by previous studies of the effects of flow on EC, and the roles of PECAM-1 in endothelial responses and in leukocyte migration. First, exposure of EC to increasing levels of shear stress in vitro leads to progressive inhibition of their response to inflammatory cytokines; EC cultured at low shear stress are less prone to recruit leukocytes than those cultured under static conditions, but more prone than those cultured at high shear stress. 21, 22 Interestingly, oscillatory shear stress, which is often associated with areas of low shear stress in the aorta, is itself proinflammatory, inducing increased expression of adhesion molecules and ability to bind monocytes. 38, 39 Acute exposure to oscillatory flow itself can lead to nuclear translocation of nuclear factor kappalight-chain-enhancer of activated B cells, a response which is reduced when PECAM-1 is absent. 20, 40 In addition, nuclear factor kappa-light-chain-enhancer of activated B cells activation in EC, which can be observed in the aortic arch of mice, was reduced in Pecam-1 -/mice. 20 Thus, there is strong evidence that loss of PECAM-1 should protect from atheroma in such regions. The literature on the effects of PECAM-1 on leukocyte migration is well established. 12, 36, 37 In the case of monocytes, especially, lack of PECAM-1 would be expected to reduce migration and hence be protective against atheroma, although the magnitude of this effect would depend on level of EC activation, which is the primary driver of leukocyte recruitment.
Effects of PECAM-1 Ablation on Disease Burden in the Descending Aorta
Examination of the descending aorta revealed that PECAM-1 total knockout mice exhibited an increase in plaque deposition within both the thoracic and abdominal aorta, leading to a net increase in deposition within the descending aorta, a phenotype previously reported in the ldlr -/model. 30 However, other studies in ApoE -/-/Pecam-1 -/models either report no change in disease burden, 28 or failed to investigate disease burden at this anatomical site. 29 Although the descending aorta is generally thought of as an atheroprotected environment because of the levels of high shear lamina flow that are present, atheromatous disease does develop, and this generally occurs at the points where the intercostal, mesenteric, and renal arteries branch from the aorta. At these points, blood flow is disturbed, and areas of low shear stress and complex flow are present, which appear to act as foci for the development of disease. When we conducted a more detailed analysis of the descending aorta, we observed that the number of disease foci was the same in ApoE -/and ApoE -/-/Pecam-1 -/animals. However, the average size of plaques was significantly increased in the absence of PECAM-1. Moreover, the distribution of disease was consistent with development of atheroma at arterial branch points. These data strongly indicate that atherosclerosis develops at branch points in the descending aorta in the presence of PECAM-1; however, in its absence, the burden of atheroma at these foci of disease is exacerbated, so that individual plaques occupy a greater surface area of the aorta.
When BM chimeras were used to discriminate between the function of the EC and hematopoietic (BM) PECAM-1 in the descending aorta, it was clear that both the BM and EC pools of PECAM-1 played a role in regulating disease burden. Within the descending aorta, as within the aortic arch, the BM pool of PECAM-1 appears to be proinflammatory, leading to a net increase in plaque burden in comparison with both the PECAM-1 null mice and the mice expressing PECAM-1 on both the BM and EC pools. However, in addition, and at variance with the analysis in the aortic arch, the EC pool of PECAM-1 also played a strong role in regulating disease burden within the descending aorta. Indeed, EC PECAM-1 effectively rescued PECAM-1 null mice from the additional burden of atheroma. In other words, in the presence of EC PECAM-1, disease progression was suppressed within the descending aorta. The data from the whole-body PECAM-1 null mice and from our chimeric studies strongly imply that the EC pool of PECAM-1 provides antiatherogenic signals. As discussed above, exposure of EC to increasing levels of shear stress in vitro leads to progressive inhibition of their response to inflammatory cytokines. Importantly, we recently showed that the inhibitory effect of laminar shear stress in such assays was lost, when the experiments were conducted on human EC in which PECAM-1 expression was reduced by treatment with small interfering RNA duplexes, or when ECs isolated from the Pecam-1 -/mouse were compared with those of wildtype animals. 23 Thus, loss of endothelial PECAM-1 would be expected to make disease worse in any situation of laminar flow, although these effects via EC would be more marked the greater the local shear stress. Bearing in mind the observations of our own studies and those in the ldlr -/-, 30 it is appropriate to speculate that this aspect of PECAM-1 function is an important regulator of disease progression, with high shear-induced signaling into ECs limiting the extent of plaque formation.
Conclusion
Our findings, and those of a previous studies, including one conducted in the ldlr -/-/Pecam-1 -/mouse, suggest that the flow characteristics of the aortic arch (ie, oscillatory disturbed flow) induce a proinflammatory environment in which PECAM-1 expressed on hemopoetic cells (BM) promotes the migration of leukocytes into tissue at sites of inflammation, which result in increased disease burden. The presence or absence of endothelial PECAM-1 at this site appears to have little influence on the progression of disease. In regions with high shear stress, such as the descending aorta, a proinflammatory environment is also produced and, similar to the situation in the aortic arch, PECAM-1 on leukocytes promotes their migration into developing lesions. However, an additional regulatory role for EC PECAM-1 is also evident. Thus, EC PECAM-1 appears to send antiinflammatory signals into (or to promote the antiinflammatory properties of) ECs, thereby moderating the burden of disease at this anatomic site. Thus, targeting EC PECAM-1 therapeutically would be expected to worsen disease. However, concentrating on inhibiting the proinflammatory properties of PECAM-1 in BM-derived cells could potentially lessen the disease profile in both high shear stress and oscillating flow regions of the aorta.
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